Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Gentian Diagnostics ASA ( (DE:6FK) ) is now available.
Kjersti Grimsrud, a board member and primary insider at Gentian Diagnostics ASA, has acquired 5,000 shares of the company at a price of NOK 46.20 each. This transaction is subject to disclosure requirements under Norwegian and EU regulations, highlighting transparency in the company’s insider trading activities.
More about Gentian Diagnostics ASA
YTD Price Performance: 23.12%
Technical Sentiment Signal: Strong Sell
Current Market Cap: €60.37M
For an in-depth examination of 6FK stock, go to TipRanks’ Stock Analysis page.